natgillin/translations-raw huggingface dataset:
Some people, depending on why they need Binocrit treatment, may later learn how to inject themselves under the skin: see Instructions on how to inject Binocrit yourself at the end of the leaflet. 
Binocritom, mogu kasnije naučiti kako da same sebi daju injekciju pod kožu: vidjeti Upute za samostalnu primjenu injekcije Binocrit na kraju ove upute.
How to use Binocrit 
Kako primjenjivati Binocrit
Diarrhoea, Nausea, Vomiting Very common 
Poremećaji probavnog sustava proljev, mučnina, povraćanje vrlo često
• in children on haemodialysis 
• u djece na hemodijalizi
• if there has been a refrigerator failure. 
- ako je došlo do kvara hladnjaka.
If you are a patient with chronic renal failure, and particularly if you do not respond properly to Binocrit, your doctor will check your dose of Binocrit because repeatedly increasing your dose of Binocrit if you are not responding to treatment may increase the risk of having a problem of the heart or the blood vessels and could increase risk of myocardial infarction, stroke and death. 
Binocritom na primjeren način, Vaš će liječnik provjeriti Vašu dozu Binocrita jer opetovano povećavanje doze Binocrita ako ne odgovarate na liječenje, može povećati rizik od tegoba sa srcem ili krvnim žilama te može povećati rizik od srčanog udara, moždanog udara i smrti.
Binocrit is used to treat anaemia in adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma (bone marrow cancer) who may have a need for a blood transfusion. 
Binocrit se primjenjuje za liječenje anemije u odraslih koji primaju kemoterapiju zbog solidnog tumora, zloćudnog limfoma ili multiplog mijeloma (rak koštane srži) i kod kojih bi mogla postojati potreba za transfuzijom krvi.
Name and address of the manufacturer responsible for batch release 
Naziv i adresa proizvođača odgovornog za puštanje serije lijeka u promet Sandoz GmbH
Your Binocrit dose and frequency of administration may be further adjusted to maintain your response to treatment. 
Dodatno Vam može prilagoditi dozu i učestalost primjene Binocrita kako bi se održao odgovor na liječenje.
Binocrit is used to treat symptomatic anaemia caused by kidney disease: 
Binocrit se primjenjuje za liječenje simptomatske anemije prouzročene bolešću bubrega:
Patients should be monitored closely to ensure that the lowest approved dose of Binocrit is used to provide adequate control of anaemia and of the symptoms of anaemia. 
Bolesnike treba pažljivo pratiti kako bi se osigurala primjena najniže odobrene doze Binocrita koja pruža odgovarajuću kontrolu anemije i simptoma anemije.
In cases where there is a medical need to shorten the lead time before surgery to less than three weeks, Binocrit 300 IU/kg should be administered subcutaneously daily for 10 consecutive days prior to surgery, on the day of surgery and for four days immediately thereafter. 
U slučajevima u kojima je iz medicinskih razloga potrebno skratiti razdoblje do kirurškog zahvata na manje od tri tjedna, treba supkutano primijeniti 300 IU/kg Binocrita dnevno tijekom 10 uzastopnih dana prije kirurškog zahvata, na sam dan kirurškog zahvata i tijekom četiri dana nakon kirurškog zahvata.
Take special care with Binocrit: 
Potreban je poseban oprez pri primjeni lijeka Binocrit:
Anaemia in chronic renal failure patients before initiation of dialysis or on peritoneal dialysis 
Anemija u bolesnika s kroničnim zatajenjem bubrega prije započinjanja dijalize ili na peritonealnoj dijalizi
Caution should be exercised with escalation of Binocrit doses in patients with chronic renal failure. 
Potreban je oprez pri povećavanju doza Binocrita u bolesnika s kroničnim zatajenjem bubrega.
Side effects from an overdose of Binocrit are unlikely. 
Nuspojave zbog predoziranja Binocritom su malo vjerojatne.
Binocrit 1,000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 2,000 IU/1 mL solution for injection in a pre-filled syringe Binocrit 3,000 IU/0.3 mL solution for injection in a pre-filled syringe Binocrit 4,000 IU/0.4 mL solution for injection in a pre-filled syringe Binocrit 5,000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 6,000 IU/0.6 mL solution for injection in a pre-filled syringe Binocrit 7,000 IU/0.7 mL solution for injection in a pre-filled syringe Binocrit 8,000 IU/0.8 mL solution for injection in a pre-filled syringe Binocrit 9,000 IU/0.9 mL solution for injection in a pre-filled syringe Binocrit 10,000 IU/1 mL solution for injection in a pre-filled syringe Binocrit 20,000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Binocrit 40,000 IU/1 mL solution for injection in a pre-filled syringe 
Binocrit 1000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 2000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 3000 IU/0,3 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 4000 IU/0,4 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 5000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 6000 IU/0,6 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 7000 IU/0,7 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 8000 IU/0,8 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 9000 IU/0,9 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 10 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 20 000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 30 000 IU/0,75 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 40 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki
“Instructions on how to inject Binocrit yourself” can be found at the end of the package leaflet. 
„Upute za samostalnu primjenu injekcije Binocrit” mogu se pronaći na kraju upute o lijeku.
- The other ingredients are: sodium dihydrogen phosphate dihydrate, disodium phosphate dihydrate, sodium chloride, glycine, polysorbate 80, hydrochloric acid (for pH-adjustment), sodium hydroxide (for pH-adjustment), and water for injections. 
- Drugi sastojci su: natrijev dihidrogenfosfat dihidrat, natrijev hidrogenfosfat dihidrat, natrijev klorid, glicin, polisorbat 80, kloridna kiselina (za podešavanje pH), natrijev hidroksid (za podešavanje pH) i voda za injekcije.
If the haemoglobin level reaches 15 g/dL (9.38 mmol/L), or higher, during the preoperative period, administration of Binocrit should be stopped and further dosages should not be administered. 
Ako tijekom predoperacijskog razdoblja razina hemoglobina postigne vrijednost od 15 g/dl (9,38 mmol/l) ili više, primjenu Binocrita treba prekinuti i više ne treba primijeniti dodatne doze.
Binocrit contains less than 1 mmol sodium (23 mg) per dose that is to say essentially “sodium free”. 
Binocrit sadrži manje od 1 mmol natrija (23 mg) po dozi, tj. zanemarive količine natrija.
What Binocrit contains - The active substance is: epoetin alfa (for quantity see the table below). 
- Djelatna tvar je: epoetin alfa (količinu vidjeti u tablici niže).
Instructions on how to inject yourself with Binocrit can be found at the end of this leaflet. 
Upute za samostalnu primjenu injekcije Binocrit nalaze se na kraju ove upute.
Package leaflet: Information for the patient Binocrit 1,000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 2,000 IU/1 mL solution for injection in a pre-filled syringe Binocrit 3,000 IU/0.3 mL solution for injection in a pre-filled syringe Binocrit 4,000 IU/0.4 mL solution for injection in a pre-filled syringe Binocrit 5,000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 6,000 IU/0.6 mL solution for injection in a pre-filled syringe Binocrit 7,000 IU/0.7 mL solution for injection in a pre-filled syringe Binocrit 8,000 IU/0.8 mL solution for injection in a pre-filled syringe Binocrit 9,000 IU/0.9 mL solution for injection in a pre-filled syringe Binocrit 10,000 IU/1 mL solution for injection in a pre-filled syringe Binocrit 20,000 IU/0.5 mL solution for injection in a pre-filled syringe Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Binocrit 40,000 IU/1 mL solution for injection in a pre-filled syringe Epoetin alfa Read all of this leaflet carefully before you start using this medicine because it contains important information for you. 
Binocrit 1000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 2000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 3000 IU/0,3 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 4000 IU/0,4 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 5000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 6000 IU/0,6 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 7000 IU/0,7 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 8000 IU/0,8 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 9000 IU/0,9 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 10 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 20 000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 30 000 IU/0,75 ml otopina za injekciju u napunjenoj štrcaljki Binocrit 40 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
The recommended dosing regimen is described in the following diagram: 150 IU/kg 3x/week or 450 IU/kg once weekly for 4 weeks 
Preporučeni raspored doziranja prikazan je u sljedećem dijagramu: 150 IU/kg 3x/tjedan ili 450 IU/kg jednom tjedno tijekom 4 tjedna povećanje broja retikulocita ≥ 40 000/µl povećanje broja retikulocita
10, A-6250 Kundl, Austria 
Sandoz GmbH, Biochemiestr. 10, A-6250 Kundl, Austrija
The starting dose is 50 IU/kg, 2 times per week. 
Početna doza je 50 IU/kg, 2 puta tjedno.
Binocrit should be administered in order to increase haemoglobin to not greater than 12 g/dL (7.5 mmol/L). 
Binocrit treba primjenjivati kako bi se hemoglobin povisio na razinu koja nije viša od 12 g/dl (7,5 mmol/l).
If after an additional 4 weeks of therapy at 300 IU/kg 3 times per week, the haemoglobin concentration has increased ≥ 1 g/dL (≥ 0.62 mmol/L) or the reticulocyte count has increased ≥ 40,000 cells/µL, the dose should remain at 300 IU/kg 3 times per week. 
Ako se nakon dodatna 4 tjedna terapije dozom od 300 IU/kg 3 puta tjedno koncentracija hemoglobina povećala za ≥ 1 g/dl (≥ 0,62 mmol/l) ili se broj retikulocita povećao za
Binocrit is indicated for the treatment of symptomatic anaemia (haemoglobin concentration of ≤ 10 g/dL) in adults with low- or intermediate-1-risk primary myelodysplastic syndromes (MDS) who have low serum erythropoietin (< 200 mU/mL). 
u odraslih s primarnim mijelodisplastičnim sindromom (MDS) niskog ili srednjeg-1 rizika koji imaju niski serumski eritropoetin (< 200 mU/ml).
Binocrit should be administered in order to increase haemoglobin to not greater than 11 g/dL (6.8 mmol/L). 
Binocrit treba primjenjivati kako bi se razina hemoglobina povisila do najviše 11 g/dl (6,8 mmol/l).
What Binocrit looks like and contents of the pack Binocrit is presented as a clear, colourless solution for injection in a pre-filled syringe. 
Binocrit je dostupan u obliku bistre, bezbojne otopine za injekciju u napunjenoj štrcaljki.
Binocrit should be administered to patients with anaemia (e.g. haemoglobin concentration ≤ 10 g/dL (6.2 mmol/L)). 
Binocrit treba primijeniti u bolesnika s anemijom (npr. koncentracija hemoglobina ≤ 10 g/dl (6,2 mmol/l)).
If the haemoglobin concentration is increasing by more than 2 g/dL (1.25 mmol/L) per month, or if the haemoglobin concentration level exceeds 12 g/dL (7.5 mmol/L), reduce the Binocrit dose by about 25 to 50%. 
Ako se koncentracija hemoglobina povećava za više od 2 g/dl (1,25 mmol/l) na mjesec, ili koncentracija hemoglobina prijeđe 12 g/dl (7,5 mmol/l), smanjite dozu Binocrita za oko 25 do 50 %.
Binocrit should be administered to patients with symptomatic anaemia (e.g. haemoglobin concentration ≤ 10 g/dL (6.2 mmol/L)). 
Lijek Binocrit treba primijeniti u bolesnika sa simptomatskom anemijom (npr. koncentracija hemoglobina ≤ 10 g/dl (6,2 mmol/l)).
Only take one dose of Binocrit from each syringe. 
Iz jedne štrcaljke uzmite samo jednu dozu lijeka Binocrit.
Treatment of adult patients with chemotherapy-induced anaemia 
Liječenje odraslih bolesnika s anemijom induciranom kemoterapijom
In paediatric patients with chronic renal failure where intravenous access is routinely available (haemodialysis patients) administration of Binocrit by the intravenous route is preferable. 
U pedijatrijskih bolesnika s kroničnim zatajenjem bubrega u kojih je rutinski dostupan intravenski pristup (bolesnici na hemodijalizi) preferira se primjena lijeka Binocrit intravenskim putem.
If the haemoglobin is rising by more than 2 g/dL (1.25 mmol/L) per month, or if the sustained haemoglobin exceeds 12 g/dL (7.5 mmol/L) reduce the Binocrit dose by 25%. 
Ako razina hemoglobina raste za više od 2 g/dl (1,25 mmol/l) na mjesec ili ako razina hemoglobina kontinuirano prelazi 12 g/dl (7,5 mmol/l) smanjite dozu Binocrita za 25 %.
If the haemoglobin exceeds 13 g/dL (8.1 mmol/L), discontinue therapy until it falls below 12 g/dL (7.5 mmol/L) and then reinstitute Binocrit therapy at a dose 25% below the previous dose. 
Ako razina hemoglobina prijeđe 13 g/dl (8,1 mmol/l), prekinite terapiju sve dok razina hemoglobina ne padne ispod 12 g/dl (7,5 mmol/l) i potom ponovno uvedite terapiju Binocritom u dozi koja je 25 % manja od prethodne doze.
If the haemoglobin concentration level exceeds 13 g/dL (8.1 mmol/L), discontinue therapy until it falls below 12 g/dL (7.5 mmol/L) and then reinitiate Binocrit therapy at a dose 25% below the previous dose. 
Ako koncentracija hemoglobina prelazi 13 g/dl (8,1 mmol/l), prekinite terapiju sve dok vrijednost ne padne ispod 12 g/dl (7,5 mmol/l) i zatim ponovno uvedite terapiju Binocritom u dozi koja je 25 % niža od prethodne.
Binocrit should not be used and discarded - if the liquid is coloured or you can see particles floating in it, - if the seal is broken, - if you know, or think that it may have been accidentally frozen, or - if there has been a refrigerator failure. 
6.6 Posebne mjere za zbrinjavanje i druga rukovanja lijekom Binocrit se ne smije primijeniti i mora se baciti - ako je tekućina obojena ili se u njoj vide plutajuće čestice, - ako je pakiranje oštećeno,
In patients with chronic renal failure where intravenous access is routinely available (haemodialysis patients) administration of Binocrit by the intravenous route is preferable. 
U bolesnika s kroničnim zatajenjem bubrega u kojih je rutinski dostupan intravenski pristup (bolesnici na hemodijalizi) preferira se primjena lijeka Binocrit intravenskim putem.
- in adults and children aged 1 to 18 years on haemodialysis and adult patients on peritoneal dialysis (see section 4.4). 
(KZB): - u odraslih i djece u dobi od 1 do 18 godina na hemodijalizi te odraslih bolesnika na peritonealnoj dijalizi (vidjeti dio 4.4). - u odraslih s insuficijencijom bubrega koji još nisu na dijalizi za liječenje teške anemije bubrežnog porijekla praćene kliničkim simptomima u bolesnika (vidjeti dio 4.4).
• Diarrhoea 
• Kašalj
Treatment of paediatric patients with chemotherapy-induced anaemia 
Liječenje pedijatrijskih bolesnika s anemijom induciranom kemoterapijom
The starting dose is 50 IU/kg intravenously, 3 times per week. 
Početna doza je 50 IU/kg intravenski, 3 puta tjedno.
Only one dose of Binocrit from each syringe should be taken. 
Jednom štrcaljkom smije se primijeniti samo jedna doza lijeka Binocrit.
Once a syringe has been removed from the refrigerator and has reached room temperature (up to 25°C) it must either be used within 3 days or disposed of. 
(do 25 °C) morate je primijeniti u roku od 3 dana ili je baciti.
Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Epoetin alfa 
Binocrit 30 000 IU/0,75 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
Name and address of the manufacturer of the biological active substance 
PUŠTANJE SERIJE LIJEKA U PROMET Naziv i adresa proizvođača biološke djelatne tvari Lek Pharmaceuticals d.d.
Binocrit 8,000 IU/0.8 mL solution for injection in a pre-filled syringe Each syringe contains 0.8 mL of solution for injection. 
Binocrit 8000 IU/0,8 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,8 ml otopine za injekciju.
INFORMATION IN BRAILLE Binocrit 30,000 IU/0.75 mL 
16. PODACI NA BRAILLEOVOM PISMU Binocrit 30 000 IU/0,75 ml
If signs and symptoms suggestive of these reactions appear, Binocrit should be withdrawn immediately and an alternative treatment considered. 
potrebno je odmah prekinuti primjenu Binocrita i razmisliti o zamjenskom liječenju.
Binocrit 9,000 IU/0.9 mL solution for injection in a pre-filled syringe Each syringe contains 0.9 mL of solution for injection. 
Binocrit 9000 IU/0,9 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,9 ml otopine za injekciju.
Binocrit 7,000 IU/0.7 mL solution for injection in a pre-filled syringe Each syringe contains 0.7 mL of solution for injection. 
Binocrit 7000 IU/0,7 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,7 ml otopine za injekciju.
INFORMATION IN BRAILLE Binocrit 8,000 IU/0.8 mL 
16. PODACI NA BRAILLEOVOM PISMU Binocrit 8000 IU/0,8 ml
INFORMATION IN BRAILLE Binocrit 9,000 IU/0.9 mL 
16. PODACI NA BRAILLEOVOM PISMU Binocrit 9000 IU/0,9 ml
Binocrit is indicated for the treatment of symptomatic anaemia associated with chronic renal failure (CRF): 
Binocrit je indiciran za liječenje simptomatske anemije povezane s kroničnim zatajenjem bubrega
Binocrit 8,000 IU/0.8 mL solution for injection in a pre-filled syringe EU/1/07/410/013 
Binocrit 8000 IU/0,8 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/013
INFORMATION IN BRAILLE Binocrit 7,000 IU/0.7 mL 
16. PODACI NA BRAILLEOVOM PISMU Binocrit 7000 IU/0,7 ml
INFORMATION IN BRAILLE Binocrit 40,000 IU/1 mL 
16. PODACI NA BRAILLEOVOM PISMU Binocrit 40 000 IU/1 ml
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 9,000 IU/0.9 mL injection 
NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Binocrit 9000 IU/0,9 ml injekcija epoetin alfa i.v./s.c.
Binocrit 9,000 IU/0.9 mL solution for injection in a pre-filled syringe 
Binocrit 9000 IU/0,9 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Each syringe contains 0.75 mL of solution for injection. 
Binocrit 30 000 IU/0,75 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,75 ml otopine za injekciju.
Binocrit 6,000 IU/0.6 mL solution for injection in a pre-filled syringe Each syringe contains 0.6 mL of solution for injection. 
Binocrit 6000 IU/0,6 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,6 ml otopine za injekciju.
INFORMATION IN BRAILLE Binocrit 6,000 IU/0.6 mL 
16. PODACI NA BRAILLEOVOM PISMU Binocrit 6000 IU/0,6 ml
Binocrit 1,000 IU/0.5 mL solution for injection in a pre-filled syringe Each mL of solution contains 2,000 IU of epoetin alfa* corresponding to 16.8 micrograms per mL 
Binocrit 1000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Jedan ml otopine sadrži 2000 IU epoetina alfa*, što odgovara 16,8 mikrograma po ml.
Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe EU/1/07/410/023 
Binocrit 30 000 IU/0,75 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/023
Binocrit 4,000 IU/0.4 mL solution for injection in a pre-filled syringe Each syringe contains 0.4 mL of solution for injection. 
Binocrit 4000 IU/0,4 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,4 ml otopine za injekciju.
Binocrit 9,000 IU/0.9 mL solution for injection in a pre-filled syringe EU/1/07/410/019 
Binocrit 9000 IU/0,9 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/019
Binocrit 6,000 IU/0.6 mL solution for injection in a pre-filled syringe EU/1/07/410/011 
Binocrit 6000 IU/0,6 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/011
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 7,000 IU/0.7 mL injection 
NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Binocrit 7000 IU/0,7 ml injekcija epoetin alfa i.v./s.c.
Binocrit 40,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL 
Binocrit 40 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki Jedan ml otopine sadrži 40 000 IU epoetina alfa*, što odgovara 336,0 mikrograma po ml.
How to store Binocrit 
Moguće nuspojave Kako čuvati Binocrit
Binocrit 8,000 IU/0.8 mL solution for injection in a pre-filled syringe 
Binocrit 8000 IU/0,8 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
Usually the injections will be given to you by a doctor, nurse or other health care professional. 
Injekcije će Vam obično davati liječnik,
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 30,000 IU/0.75 mL injection 
NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Binocrit 30 000 IU/0,75 ml injekcija epoetin alfa i.v./s.c.
Binocrit 20,000 IU/0.5 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL 
Binocrit 20 000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Jedan ml otopine sadrži 40 000 IU epoetina alfa*, što odgovara 336,0 mikrograma po ml.
INFORMATION IN BRAILLE Binocrit 4,000 IU/0.4 mL 
16. PODACI NA BRAILLEOVOM PISMU Binocrit 4000 IU/0,4 ml
Binocrit 7,000 IU/0.7 mL solution for injection in a pre-filled syringe EU/1/07/410/017 
Binocrit 7000 IU/0,7 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/017
Binocrit 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL 
Binocrit 30 000 IU/0,75 ml otopina za injekciju u napunjenoj štrcaljki Jedan ml otopine sadrži 40 000 IU epoetina alfa*, što odgovara 336,0 mikrograma po ml.
Binocrit 5,000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/410/009 
Binocrit 5000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/009
INFORMATION IN BRAILLE Binocrit 20,000 IU/0.5 mL 
16. PODACI NA BRAILLEOVOM PISMU Binocrit 20 000 IU/0,5 ml
Binocrit 7,000 IU/0.7 mL solution for injection in a pre-filled syringe 
Binocrit 7000 IU/0,7 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
Binocrit 2,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 2,000 IU of epoetin alfa* corresponding to 16.8 micrograms per mL 
Binocrit 2000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki Jedan ml otopine sadrži 2000 IU epoetina alfa*, što odgovara 16,8 mikrograma po ml.
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 8,000 IU/0.8 mL injection 
NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Binocrit 8000 IU/0,8 ml injekcija epoetin alfa i.v./s.c.
Binocrit 5,000 IU/0.5 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL 
Binocrit 5000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Jedan ml otopine sadrži 10 000 IU epoetina alfa*, što odgovara 84,0 mikrograma po ml.
Binocrit 20,000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/410/021 
Binocrit 20 000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/021
Binocrit 6,000 IU/0.6 mL solution for injection in a pre-filled syringe 
Binocrit 6000 IU/0,6 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
INFORMATION IN BRAILLE Binocrit 3,000 IU/0.3 mL 
16. PODACI NA BRAILLEOVOM PISMU Binocrit 3000 IU/0,3 ml
Binocrit 4,000 IU/0.4 mL solution for injection in a pre-filled syringe EU/1/07/410/007 
Binocrit 4000 IU/0,4 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/007
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Binocrit 6,000 IU/0.6 mL injection 
NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Binocrit 6000 IU/0,6 ml injekcija epoetin alfa i.v./s.c.
Binocrit 40,000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/410/025 
Binocrit 40 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/410/025